PureTech Health (PRTC) Research & Development (2023 - 2025)

PureTech Health (PRTC) has 3 years of Research & Development data on file, last reported at -$24.9 million in Q2 2025.

• Research & Development for Q2 2025 came in at -$24.9 million, up 36.04% year-over-year; the trailing twelve-month figure through Jun 2025 was -$155.9 million (changed N/A YoY), and the FY2025 annual result was -$56.6 million, up 18.55% from the prior year.
• Research & Development climbed to -$24.9 million in Q2 2025 per PRTC's latest filing, from -$38.9 million in the prior quarter.
• Over five years, Research & Development peaked at -$24.9 million in Q2 2025 and troughed at -$53.1 million in Q4 2023.
• A 3-year average of -$39.0 million and a median of -$38.9 million in 2024 frame the typical range for Research & Development.
• The sharpest annual moves came in 2024 and 2025: Research & Development rose 26.75% in 2024, then surged 36.04% in 2025.
• A 3-year view of Research & Development shows it stood at -$53.1 million in 2023, then climbed by 26.75% to -$38.9 million in 2024, then surged by 36.04% to -$24.9 million in 2025.
• Business Quant data shows PRTC's Research & Development at -$24.9 million in Q2 2025, -$38.9 million in Q4 2024, and -$38.9 million in Q2 2024.